Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
biotech
clinical trials
4
×
eli lilly
life sciences
merck
4
×
national
national blog main
national top stories
new york blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
alzheimer's disease
bristol-myers squibb
cancer immunotherapy
car-t immunotherapy
crispr
What
bio
companies
roundup
approved
drug
fda
nash
new
news
treatment
adults
allergan
approval
biogen’s
biopharmaceutical
black
class
continue
convo
debut
diamond
diamond’s
digital
disease
earlier
epidemic
failures
fatty
frenzied
growing
indication
known
leading
led
life
littered
liver
mammoth
march
medicines
Language
unset
Current search:
abbvie
×
merck
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More